Stay updated on MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Sign up to get notified when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.

Latest updates to the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov site footer now identifies the platform as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check12 days agoChange DetectedA sitewide NIH notice says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and points visitors to updates and FAQs.SummaryDifference0.6%

- Check19 days agoChange DetectedThe ClinicalTrials.gov footer now displays website revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check26 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check47 days agoChange DetectedThe Record History page text changes include the link text capitalization for contacting information and the addition of a new revision label (Revision: v3.7.0), while the previous label (Revision: v3.6.6) and the old link text were removed.SummaryDifference0.2%

- Check68 days agoChange DetectedThe study record's revision history was updated to include a new revision (v3.6.6) and remove the previous one (v3.6.5), reflecting an update to the page's history log.SummaryDifference0.1%

Stay in the know with updates to MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.